Home treatment of haemophilia patients with inhibitors

被引:14
作者
Oyesiku, J. O. O. [1 ,2 ]
机构
[1] Churchill Hosp, Oxford Haemophilia Ctr, Oxford OX3 7LJ, England
[2] Churchill Hosp, Thrombosis Ctr, Oxford OX3 7LJ, England
关键词
haemophilia; home treatment; inhibitors; recombinant activated factor VII; ACTIVATED FACTOR-VII; QUALITY-OF-LIFE; BLEEDING EPISODES; ORTHOPEDIC STATUS; DOUBLE-BLIND; EFFICACY; RFVIIA; NOVOSEVEN; CHILDREN; THERAPY;
D O I
10.1111/j.1365-2516.2010.02418.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Bleeding episodes in patients with inhibitors can be challenging to treat. Clinical guidelines recognize the importance of early treatment, ideally within 2 h of the onset of bleeding. On-demand haemophilia care at home has been shown to reduce the time between recognition of the symptoms of bleeding and initiation of treatment. Rapid resolution of bleeding is associated with longer-term benefits for the patient. Effective haemophilia care at home depends on patients and carers taking greater responsibility for treatment; however, many find this difficult. Education can help raise awareness of haemophilia treatment at home and provide helpful information for patients/carers. The haemophilia nurse has a key role in providing this support and education. This review discusses a number of recent guidelines and educational materials for haemophilia home care identified during a literature survey. The survey shows that most materials were not validated. In addition, the survey shows limited effectiveness data on techniques for training haemophilia patients about home care. Further education resources and research in the treatment of haemophilia at home are required.
引用
收藏
页码:173 / 178
页数:6
相关论文
共 45 条
[31]   HEMOPHILIA HOME TREATMENT - ECONOMIC-ANALYSIS AND IMPLICATIONS FOR HEALTH-POLICY [J].
ROSSDEGNAN, D ;
SOUMERAI, SB ;
AVORN, J ;
BOHN, RL ;
BRIGHT, R ;
ALEDORT, LM .
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 1995, 11 (02) :327-344
[32]   Effect of rFVIIa dose and time to treatment on patients with haemophilia and inhibitors: analysis of HemoRec registry data from the Czech Republic [J].
Salaj, P. ;
Brabec, P. ;
Penka, M. ;
Pohlreichova, V. ;
Smejkal, P. ;
Cetkovsky, P. ;
Dusek, L. ;
Hedner, U. .
HAEMOPHILIA, 2009, 15 (03) :752-759
[33]   The need for speed in the management of haemophilia patients with inhibitors [J].
Salek, S. Z. ;
Benson, G. M. ;
Elezovic, I. ;
Krenn, V. ;
Ljung, R. C. R. ;
Morfini, M. ;
Remor, E. ;
Santagostino, E. ;
Sorensen, B. .
HAEMOPHILIA, 2011, 17 (01) :95-102
[34]   Home treatment with recombinant activated factor VII in patients with factor VIII inhibitors: the advantages of early intervention [J].
Santagostino, E ;
Gringeri, A ;
Mannucci, PM .
BRITISH JOURNAL OF HAEMATOLOGY, 1999, 104 (01) :22-26
[35]   Quality of life is associated to the orthopaedic status in haemophilic patients with inhibitors [J].
Scalone, L ;
Mantovani, LG ;
Mannucci, PM ;
Gringeri, A .
HAEMOPHILIA, 2006, 12 (02) :154-162
[36]   Patients', physicians', and pharmacists' preferences towards coagulation factor concentrates to treat haemophilia with inhibitors: results from the COHIBA Study [J].
Scalone, L. ;
Mantovani, L. G. ;
Borghetti, F. ;
Von Mackensen, S. ;
Gringeri, A. .
HAEMOPHILIA, 2009, 15 (02) :473-486
[37]   The impact on parents of developments in the care of children with bleeding disorders [J].
Shaw, D. ;
Riley, G. A. .
HAEMOPHILIA, 2008, 14 (01) :65-67
[38]   FEIBA® in treatment of acute bleeding episodes in patients with haemophilia A and factor VIII inhibitors: a retrospective survey in regional haemophilia centre [J].
Smejkal, P. ;
Brabec, P. ;
Matyskova, M. ;
Bulikova, A. ;
Slechtova, M. ;
Kissova, J. ;
Chlupova, G. ;
Muzik, J. ;
Penka, M. .
HAEMOPHILIA, 2009, 15 (03) :743-751
[39]  
Stewart AJ, 1998, BLOOD COAGUL FIBRIN, V9, pS93
[40]   Efficacy of recombinant activated factor VII vs. activated prothrombin complex concentrate for patients suffering from haemophilia complicated with inhibitors: a Bayesian meta-regression [J].
Treur, M. J. ;
Mccracken, F. ;
Heeg, B. ;
Joshi, A. V. ;
Botteman, M. F. ;
De Charro, F. ;
Van Hout, B. .
HAEMOPHILIA, 2009, 15 (02) :420-436